Frontlight ResearchEarly access
Trial site
The Third Xiangya Hospital of Central South University
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Migraine2 trials
- Coronary artery disease1 trial
- Pancreatic cancer1 trial
- Phase
- Early phase 11 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Not yet recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- Brise Pharmaceuticals Co., Ltd.2 trials
- Changhai Hospital1 trial
- Harbin Medical University1 trial
- The Third Xiangya Hospital of Central South University1 trial
Running trials
Not yet recruiting
Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
Recruiting
Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Not yet recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine2 recruiting
- Coronary artery disease1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026